Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Peritoneal Dialysis-associated Peritonitis, Vitamin D Deficiency

In brief

This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.

Key facts

Study ID
NCT05860270
Run by
Peking University First Hospital
People needed
176
Starts
2023-06-15
Expected to finish
2026-05-31
Last updated by the study team
2024-08-06

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.